Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 424B5 Offering Prospectus
  2. SC 13G Stake Amended Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Other events
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. EFFECT Other Notice of Effectiveness
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. S-3 Offering Registration Statement

Page 10 of 68 · 1,358 filings